Trending NewsTrending NewsNASDAQ:TEM Tempus AI (TEM) Stock Price, News & Analysis $59.01 +0.27 (+0.46%) Closing price 09/11/2026 04:00 PM EasternExtended Trading$59.00 -0.01 (-0.02%) As of 09/11/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Tempus AI Stock (NASDAQ:TEM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tempus AI alerts:Sign Up Key Stats Today's Range$58.48▼$60.3850-Day Range$41.55▼$72.6952-Week Range$40.77▼$104.32Volume3.68 million shsAverage Volume7.77 million shsMarket Capitalization$10.65 billionP/E RatioN/ADividend YieldN/APrice Target$69.33Consensus RatingHold Company Overview Tempus AI, Inc. is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies. Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management. The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States. Tempus was founded in 2015 by Eric Lefkofsky, who serves as its chief executive officer. The company became publicly traded on the Nasdaq under the symbol TEM in 2024.AI Generated. May Contain Errors. Read More Tempus AI Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreTEM MarketRank™: Tempus AI scored higher than 61% of companies evaluated by MarketBeat, and ranked 384th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingTempus AI has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 11 buy ratings, 8 hold ratings, and 2 sell ratings.Upside PotentialTempus AI has a consensus price target of $69.33, representing about 17.5% upside from its current price of $59.01.Amount of Analyst CoverageTempus AI has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tempus AI's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tempus AI are expected to grow in the coming year, from ($1.38) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tempus AI is -40.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tempus AI is -40.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTempus AI has a P/B Ratio of 21.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tempus AI's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted21.56% of the float of Tempus AI has been sold short.Short Interest Ratio / Days to CoverTempus AI has a short interest ratio ("days to cover") of 2.92, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Tempus AI has recently decreased by 1.36%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTempus AI does not currently pay a dividend.Dividend GrowthTempus AI does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.74 News SentimentTempus AI has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.86 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Tempus AI this week, compared to 10 articles on an average week.Search InterestOnly 51 people have searched for TEM on MarketBeat in the last 30 days. This is a decrease of -4% compared to the previous 30 days.MarketBeat Follows19 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 12% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $56,963,417.00 in company stock.Percentage Held by Insiders24.26% of the stock of Tempus AI is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions24.22% of the stock of Tempus AI is held by institutions.Read more about Tempus AI's insider trading history. Receive TEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tempus AI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEM Stock News HeadlinesTempus AI to Build Dataset of 100,000 Whole Genomes for AI Research52 minutes ago | marketwatch.comTempus AI Building Multimodal Whole-Genome Dataset for AI ResearchSeptember 11 at 2:25 PM | finance.yahoo.comA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One executive order could change that — potentially triggering the largest wealth transfer into gold in modern American history. The last time the U.S. faced this combination of inflation, debt, and monetary pressure, gold climbed 2,300% in the 1970s. Reagan Gold Group's free 2026 Gold Guide breaks down what investors need to know now. | Reagan Gold Group (Ad)Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare InnovationSeptember 11 at 9:00 AM | businesswire.comNvidia, Snowflake, Chubb And A Health Care Stock On CNBC's ‘Final Trades'September 11 at 8:45 AM | benzinga.comTempus AI (NASDAQ:TEM) Director Nadja West Sells 3,000 SharesSeptember 2, 2026 | insidertrades.comTempus AI (NASDAQ:TEM) CEO Ryan Fukushima Sells 14,286 Shares of StockAugust 26, 2026 | insidertrades.comTempus AI (NASDAQ:TEM) CAO Ryan Bartolucci Sells 6,175 SharesAugust 21, 2026 | insidertrades.comSee More Headlines TEM Stock Analysis - Frequently Asked Questions How have TEM shares performed this year? Tempus AI's stock was trading at $59.05 at the beginning of 2026. Since then, TEM stock has decreased by 0.1% and is now trading at $59.01. How were Tempus AI's earnings last quarter? Tempus AI, Inc. (NASDAQ:TEM) issued its earnings results on Thursday, July, 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.10. The business's quarterly revenue was up 21.6% on a year-over-year basis. Read the conference call transcript. When did Tempus AI IPO? Tempus AI (TEM) raised $400 million in an IPO on Wednesday, June 12th 2024. The company issued 11,100,000 shares at a price of $35.00-$37.00 per share. Who are Tempus AI's major shareholders? Top institutional shareholders of Tempus AI include California State Teachers Retirement System (3.87%), Wellington Management Group LLP (0.22%), Washington Trust Advisors Inc. (0.05%) and Headlands Technologies LLC (0.03%). Insiders that own company stock include Bradley A Keywell, Eric P Lefkofsky, Andrew Polovin, James William Rogers, Erik Phelps, Ryan M Bartolucci, Ryan Fukushima, Nadja West, David R Epstein and Jennifer A Doudna. View institutional ownership trends. How do I buy shares of Tempus AI? Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tempus AI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI). Company Calendar Last Earnings7/30/2026Today9/11/2026Morgan Stanley 24th Annual Global Healthcare Conference9/15/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 3 weeks, TEM's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:TEM Previous SymbolNASDAQ:TEM CIK1717115 Webwww.tempus.com Phone800-976-5448FaxN/AEmployees3,800Year Founded2015Price Target and Rating Average Price Target for Tempus AI$69.33 High Price Target$100.00 Low Price Target$35.00 Potential Upside/Downside+17.5%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)($1.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$245.03 million Net Margins-17.77% Pretax Margin-17.62% Return on Equity-50.28% Return on Assets-10.33% Debt Debt-to-Equity Ratio3.06 Current Ratio3.30 Quick Ratio3.16 Sales & Book Value Annual Sales$1.27 billion Price / Sales8.37 Cash FlowN/A Price / Cash FlowN/A Book Value$2.76 per share Price / Book21.38Miscellaneous Outstanding Shares180,430,000Free Float136,661,000Market Cap$10.65 billion OptionableN/A Beta3.72 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:TEM) was last updated on 9/12/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis metric called 1929, 1969 and 2000 [it's screaming now]The Buffett Indicator once flagged the 1929, 1969, and 2000 market peaks - and it's now at 231%, its highest r...Golden Portfolio | SponsoredThe retirement income that answers “yes” when everything else says noTodd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...Eagle Publishing | SponsoredElon’s “nude” scandal – a big opportunity?Louis Navellier, the quantitative analyst who called Nvidia before its 44,000% run, says Elon Musk's AI ambiti...InvestorPlace | SponsoredMy ‘one day’ retirement secretTradeSmith's AI research team, backed by a $17 million investment and led by a former NSA codebreaker, built a...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempus AI, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempus AI With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
